N-(4-methyl-5-(2-(methylsulfonyl)oxazol-5-yl)thiazol-2-yl)acetamide

ID: ALA2204778

Chembl Id: CHEMBL2204778

PubChem CID: 71450452

Max Phase: Preclinical

Molecular Formula: C10H11N3O4S2

Molecular Weight: 301.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1nc(C)c(-c2cnc(S(C)(=O)=O)o2)s1

Standard InChI:  InChI=1S/C10H11N3O4S2/c1-5-8(18-9(12-5)13-6(2)14)7-4-11-10(17-7)19(3,15)16/h4H,1-3H3,(H,12,13,14)

Standard InChI Key:  OFOXQNICEHYXRI-UHFFFAOYSA-N

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pik3cg Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.35Molecular Weight (Monoisotopic): 301.0191AlogP: 1.47#Rotatable Bonds: 3
Polar Surface Area: 102.16Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.95CX Basic pKa: CX LogP: -0.28CX LogD: -0.39
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.92Np Likeness Score: -1.63

References

1. Oka Y, Yabuuchi T, Fujii Y, Ohtake H, Wakahara S, Matsumoto K, Endo M, Tamura Y, Sekiguchi Y..  (2012)  Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors.,  22  (24): [PMID:23122859] [10.1016/j.bmcl.2012.10.028]

Source